Global Exosome Therapeutics Supply, Demand and Key Producers, 2023-2029

February 2023 | 111 pages | ID: G42C1020D9B9EN
GlobalInfoResearch

Abstracts

The global Exosome Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Exosome Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Exosome Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Exosome Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Exosome Therapeutics total market, 2018-2029, (USD Million)

Global Exosome Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Exosome Therapeutics total market, key domestic companies and share, (USD Million)

Global Exosome Therapeutics revenue by player and market share 2018-2023, (USD Million)

Global Exosome Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)

Global Exosome Therapeutics total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Exosome Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, EV Therapeutics, Evox Therapeutics, ExoCoBio, ILIAS Biologics and Rion, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Exosome Therapeutics market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Exosome Therapeutics Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Exosome Therapeutics Market, Segmentation by Type

• Monotherapy
• Combination Therapy

Global Exosome Therapeutics Market, Segmentation by Application

• Hospitals
• Clinics & Ambulatory Centers
• Cancer Research Institutes
• Others

Companies Profiled:

• Cellular Biomedicine Group
• Codiak BioSciences
• Coya Therapeutics
• Curexsys
• EV Therapeutics
• Evox Therapeutics
• ExoCoBio
• ILIAS Biologics
• Rion
• SHIFTBIO

Key Questions Answered

1. How big is the global Exosome Therapeutics market?

2. What is the demand of the global Exosome Therapeutics market?

3. What is the year over year growth of the global Exosome Therapeutics market?

4. What is the total value of the global Exosome Therapeutics market?

5. Who are the major players in the global Exosome Therapeutics market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Exosome Therapeutics Introduction
1.2 World Exosome Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Exosome Therapeutics Total Market by Region (by Headquarter Location)
  1.3.1 World Exosome Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Exosome Therapeutics Market Size (2018-2029)
  1.3.3 China Exosome Therapeutics Market Size (2018-2029)
  1.3.4 Europe Exosome Therapeutics Market Size (2018-2029)
  1.3.5 Japan Exosome Therapeutics Market Size (2018-2029)
  1.3.6 South Korea Exosome Therapeutics Market Size (2018-2029)
  1.3.7 ASEAN Exosome Therapeutics Market Size (2018-2029)
  1.3.8 India Exosome Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Exosome Therapeutics Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Exosome Therapeutics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Exosome Therapeutics Consumption Value (2018-2029)
2.2 World Exosome Therapeutics Consumption Value by Region
  2.2.1 World Exosome Therapeutics Consumption Value by Region (2018-2023)
  2.2.2 World Exosome Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States Exosome Therapeutics Consumption Value (2018-2029)
2.4 China Exosome Therapeutics Consumption Value (2018-2029)
2.5 Europe Exosome Therapeutics Consumption Value (2018-2029)
2.6 Japan Exosome Therapeutics Consumption Value (2018-2029)
2.7 South Korea Exosome Therapeutics Consumption Value (2018-2029)
2.8 ASEAN Exosome Therapeutics Consumption Value (2018-2029)
2.9 India Exosome Therapeutics Consumption Value (2018-2029)

3 WORLD EXOSOME THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS

3.1 World Exosome Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Exosome Therapeutics Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Exosome Therapeutics in 2022
  3.2.3 Global Concentration Ratios (CR8) for Exosome Therapeutics in 2022
3.3 Exosome Therapeutics Company Evaluation Quadrant
3.4 Exosome Therapeutics Market: Overall Company Footprint Analysis
  3.4.1 Exosome Therapeutics Market: Region Footprint
  3.4.2 Exosome Therapeutics Market: Company Product Type Footprint
  3.4.3 Exosome Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Exosome Therapeutics Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Exosome Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Exosome Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Exosome Therapeutics Consumption Value Comparison
  4.2.1 United States VS China: Exosome Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Exosome Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Exosome Therapeutics Companies and Market Share, 2018-2023
  4.3.1 United States Based Exosome Therapeutics Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Exosome Therapeutics Revenue, (2018-2023)
4.4 China Based Companies Exosome Therapeutics Revenue and Market Share, 2018-2023
  4.4.1 China Based Exosome Therapeutics Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Exosome Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based Exosome Therapeutics Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Exosome Therapeutics Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Exosome Therapeutics Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Exosome Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Monotherapy
  5.2.2 Combination Therapy
5.3 Market Segment by Type
  5.3.1 World Exosome Therapeutics Market Size by Type (2018-2023)
  5.3.2 World Exosome Therapeutics Market Size by Type (2024-2029)
  5.3.3 World Exosome Therapeutics Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Exosome Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Clinics & Ambulatory Centers
  6.2.3 Cancer Research Institutes
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Exosome Therapeutics Market Size by Application (2018-2023)
  6.3.2 World Exosome Therapeutics Market Size by Application (2024-2029)
  6.3.3 World Exosome Therapeutics Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Cellular Biomedicine Group
  7.1.1 Cellular Biomedicine Group Details
  7.1.2 Cellular Biomedicine Group Major Business
  7.1.3 Cellular Biomedicine Group Exosome Therapeutics Product and Services
  7.1.4 Cellular Biomedicine Group Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Cellular Biomedicine Group Recent Developments/Updates
  7.1.6 Cellular Biomedicine Group Competitive Strengths & Weaknesses
7.2 Codiak BioSciences
  7.2.1 Codiak BioSciences Details
  7.2.2 Codiak BioSciences Major Business
  7.2.3 Codiak BioSciences Exosome Therapeutics Product and Services
  7.2.4 Codiak BioSciences Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Codiak BioSciences Recent Developments/Updates
  7.2.6 Codiak BioSciences Competitive Strengths & Weaknesses
7.3 Coya Therapeutics
  7.3.1 Coya Therapeutics Details
  7.3.2 Coya Therapeutics Major Business
  7.3.3 Coya Therapeutics Exosome Therapeutics Product and Services
  7.3.4 Coya Therapeutics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Coya Therapeutics Recent Developments/Updates
  7.3.6 Coya Therapeutics Competitive Strengths & Weaknesses
7.4 Curexsys
  7.4.1 Curexsys Details
  7.4.2 Curexsys Major Business
  7.4.3 Curexsys Exosome Therapeutics Product and Services
  7.4.4 Curexsys Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Curexsys Recent Developments/Updates
  7.4.6 Curexsys Competitive Strengths & Weaknesses
7.5 EV Therapeutics
  7.5.1 EV Therapeutics Details
  7.5.2 EV Therapeutics Major Business
  7.5.3 EV Therapeutics Exosome Therapeutics Product and Services
  7.5.4 EV Therapeutics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 EV Therapeutics Recent Developments/Updates
  7.5.6 EV Therapeutics Competitive Strengths & Weaknesses
7.6 Evox Therapeutics
  7.6.1 Evox Therapeutics Details
  7.6.2 Evox Therapeutics Major Business
  7.6.3 Evox Therapeutics Exosome Therapeutics Product and Services
  7.6.4 Evox Therapeutics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Evox Therapeutics Recent Developments/Updates
  7.6.6 Evox Therapeutics Competitive Strengths & Weaknesses
7.7 ExoCoBio
  7.7.1 ExoCoBio Details
  7.7.2 ExoCoBio Major Business
  7.7.3 ExoCoBio Exosome Therapeutics Product and Services
  7.7.4 ExoCoBio Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 ExoCoBio Recent Developments/Updates
  7.7.6 ExoCoBio Competitive Strengths & Weaknesses
7.8 ILIAS Biologics
  7.8.1 ILIAS Biologics Details
  7.8.2 ILIAS Biologics Major Business
  7.8.3 ILIAS Biologics Exosome Therapeutics Product and Services
  7.8.4 ILIAS Biologics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 ILIAS Biologics Recent Developments/Updates
  7.8.6 ILIAS Biologics Competitive Strengths & Weaknesses
7.9 Rion
  7.9.1 Rion Details
  7.9.2 Rion Major Business
  7.9.3 Rion Exosome Therapeutics Product and Services
  7.9.4 Rion Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Rion Recent Developments/Updates
  7.9.6 Rion Competitive Strengths & Weaknesses
7.10 SHIFTBIO
  7.10.1 SHIFTBIO Details
  7.10.2 SHIFTBIO Major Business
  7.10.3 SHIFTBIO Exosome Therapeutics Product and Services
  7.10.4 SHIFTBIO Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 SHIFTBIO Recent Developments/Updates
  7.10.6 SHIFTBIO Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Exosome Therapeutics Industry Chain
8.2 Exosome Therapeutics Upstream Analysis
8.3 Exosome Therapeutics Midstream Analysis
8.4 Exosome Therapeutics Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Exosome Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Exosome Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Exosome Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Exosome Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Exosome Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Exosome Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Exosome Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Exosome Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Exosome Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Exosome Therapeutics Players in 2022
Table 12. World Exosome Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Exosome Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key Exosome Therapeutics Player
Table 15. Exosome Therapeutics Market: Company Product Type Footprint
Table 16. Exosome Therapeutics Market: Company Product Application Footprint
Table 17. Exosome Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China Exosome Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Exosome Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Exosome Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Exosome Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Exosome Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based Exosome Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Exosome Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Exosome Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Exosome Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Exosome Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Exosome Therapeutics Revenue Market Share (2018-2023)
Table 29. World Exosome Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Exosome Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Exosome Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Exosome Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Exosome Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Exosome Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. Cellular Biomedicine Group Basic Information, Area Served and Competitors
Table 36. Cellular Biomedicine Group Major Business
Table 37. Cellular Biomedicine Group Exosome Therapeutics Product and Services
Table 38. Cellular Biomedicine Group Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cellular Biomedicine Group Recent Developments/Updates
Table 40. Cellular Biomedicine Group Competitive Strengths & Weaknesses
Table 41. Codiak BioSciences Basic Information, Area Served and Competitors
Table 42. Codiak BioSciences Major Business
Table 43. Codiak BioSciences Exosome Therapeutics Product and Services
Table 44. Codiak BioSciences Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Codiak BioSciences Recent Developments/Updates
Table 46. Codiak BioSciences Competitive Strengths & Weaknesses
Table 47. Coya Therapeutics Basic Information, Area Served and Competitors
Table 48. Coya Therapeutics Major Business
Table 49. Coya Therapeutics Exosome Therapeutics Product and Services
Table 50. Coya Therapeutics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Coya Therapeutics Recent Developments/Updates
Table 52. Coya Therapeutics Competitive Strengths & Weaknesses
Table 53. Curexsys Basic Information, Area Served and Competitors
Table 54. Curexsys Major Business
Table 55. Curexsys Exosome Therapeutics Product and Services
Table 56. Curexsys Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Curexsys Recent Developments/Updates
Table 58. Curexsys Competitive Strengths & Weaknesses
Table 59. EV Therapeutics Basic Information, Area Served and Competitors
Table 60. EV Therapeutics Major Business
Table 61. EV Therapeutics Exosome Therapeutics Product and Services
Table 62. EV Therapeutics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. EV Therapeutics Recent Developments/Updates
Table 64. EV Therapeutics Competitive Strengths & Weaknesses
Table 65. Evox Therapeutics Basic Information, Area Served and Competitors
Table 66. Evox Therapeutics Major Business
Table 67. Evox Therapeutics Exosome Therapeutics Product and Services
Table 68. Evox Therapeutics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Evox Therapeutics Recent Developments/Updates
Table 70. Evox Therapeutics Competitive Strengths & Weaknesses
Table 71. ExoCoBio Basic Information, Area Served and Competitors
Table 72. ExoCoBio Major Business
Table 73. ExoCoBio Exosome Therapeutics Product and Services
Table 74. ExoCoBio Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. ExoCoBio Recent Developments/Updates
Table 76. ExoCoBio Competitive Strengths & Weaknesses
Table 77. ILIAS Biologics Basic Information, Area Served and Competitors
Table 78. ILIAS Biologics Major Business
Table 79. ILIAS Biologics Exosome Therapeutics Product and Services
Table 80. ILIAS Biologics Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ILIAS Biologics Recent Developments/Updates
Table 82. ILIAS Biologics Competitive Strengths & Weaknesses
Table 83. Rion Basic Information, Area Served and Competitors
Table 84. Rion Major Business
Table 85. Rion Exosome Therapeutics Product and Services
Table 86. Rion Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Rion Recent Developments/Updates
Table 88. SHIFTBIO Basic Information, Area Served and Competitors
Table 89. SHIFTBIO Major Business
Table 90. SHIFTBIO Exosome Therapeutics Product and Services
Table 91. SHIFTBIO Exosome Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Exosome Therapeutics Upstream (Raw Materials)
Table 93. Exosome Therapeutics Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Exosome Therapeutics Picture
Figure 2. World Exosome Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Exosome Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Exosome Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Exosome Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Exosome Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. Exosome Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Exosome Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Exosome Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Exosome Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Exosome Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Exosome Therapeutics Markets in 2022
Figure 27. United States VS China: Exosome Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Exosome Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Exosome Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Exosome Therapeutics Market Size Market Share by Type in 2022
Figure 31. Monotherapy
Figure 32. Combination Therapy
Figure 33. World Exosome Therapeutics Market Size Market Share by Type (2018-2029)
Figure 34. World Exosome Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Exosome Therapeutics Market Size Market Share by Application in 2022
Figure 36. Hospitals
Figure 37. Clinics & Ambulatory Centers
Figure 38. Cancer Research Institutes
Figure 39. Others
Figure 40. Exosome Therapeutics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source